Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
270 USD | +0.22% | +0.39% | -6.26% |
05:03pm | Amgen to Submit Thyroid Eye Disease Treatment Marketing Authorization Application in Europe | MT |
03:38pm | Amgen to Seek European OK of Thyroid Eye Disease Drug Tepezza | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.26% | 144B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-11.77% | 143B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Amgen's Lumykras Approved by European Commission for Non-Small Cell Lung Cancer